Genmab | GEN - Ordinary Share Capital


Genmab reported DKK61.62M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agios Pharmaceuticals USD 58.45M 169K Dec/2025
Almirall EUR 214.79M 0 Dec/2025
Amarin USD 20.81M 13K Dec/2025
Amgen USD 539M 1000K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Bayer EUR 982.42M 0 Dec/2025
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
Demant DKK 210.9M 5.18M Dec/2025
Exelixis USD 268.1M 2.03M Sep/2025
Fresenius Medical Care EUR 279.29M 10.56M Dec/2025
Galapagos EUR 65.9M 0 Dec/2025
Genmab DKK 61.62M 52K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
GN Store Nord DKK 145.61M 458.39M Sep/2025
GRIFOLS EUR 680.58M 846K Dec/2025
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Insmed USD 214.26M 1.67M Dec/2025
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
UCB EUR 190.36M 365.15K Dec/2025